Use of linezolid in children: Introduction

Pediatric Infectious Disease Journal

Volumn 22, Issue 9 SUPPL., 2003, Pages

  Kaplan, Sheldon L ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Gram positive cocci; Linezolid; Oxazolidinones

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CLINDAMYCIN; DALFOPRISTIN; ERYTHROMYCIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; OXAZOLIDINONE DERIVATIVE; QUINUPRISTIN; STREPTOGRAMIN;

ANTIBIOTIC RESISTANCE; DRUG APPROVAL; DRUG INDICATION; DRUG INFORMATION; DRUG MECHANISM; EDITORIAL; ENTEROCOCCUS; FOOD AND DRUG ADMINISTRATION; LISTERIA MONOCYTOGENES; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STREPTOCOCCUS; STRUCTURE ACTIVITY RELATION;

EID: 0141792746     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000086953.15453.15     Document Type: Editorial

References (14)

1. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 1998;42:3251-5.
2. Gonzales RD, Schreckenberger PC, Graham MB, Kelkar S, Den Besten K, Quinn JP. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 2001;357:1179.
3. Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001;358:207-8.
4. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus: Pennsylvania, 2002. MMWR 2002;51:902.
5. Moellering RC Jr. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003;138:135-42.
6. FDA Advisory Committee Presentation. http://www.fda.gov/ohrms/dockets/as/00/slides.
7. Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet 2001;358:1975-82.
8. Wallace RJ Jr., Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 2001;45:764-7.
9. Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW, Wallace RJ Jr. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother 2001;45:1295-7.
10. Brown-Elliott BA, Wallace RJ Jr., Blinkhorn R, et al. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis 2001;33:1433-4.
11. Moylett EH, Pacheco SE, Brown-Elliott BA, et al. Clinical experience with linezolid for the treatment of Nocardia infection. Clin Infect Dis 2003;36:313-8.
12. Kaplan SL, Deville JG, Yogev R, et al. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J 2003;22:677-85.
13. Kaplan SL, Patterson L, Edwards KM, and the Linezolid Pediatric Pneumonia Study Group. Linezolid treatment of community-acquired pneumonia in hospitalized children. Pediatr Infect Dis J 2001;20:488-94.
14. Wible K, Tregnaghi M, Bruss J, Fleishaker D, Naberhuis-Stehuwer S, Hilty M. Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children. Pediatr Infect Dis J 2003;22:315-22.